D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 119 Citations 66,207 607 World Ranking 1639 National Ranking 50

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Surgery

Robert Landewé mostly deals with Internal medicine, Rheumatoid arthritis, Physical therapy, Ankylosing spondylitis and Surgery. His Internal medicine research incorporates themes from Gastroenterology and Placebo. The study incorporates disciplines such as Erythrocyte sedimentation rate, Connective tissue disease and Methotrexate in addition to Rheumatoid arthritis.

His Physical therapy research integrates issues from Clinical trial, Systematic review, Rheumatism, Evidence-based medicine and Severity of illness. His study looks at the relationship between Ankylosing spondylitis and fields such as Cohort, as well as how they intersect with chemical problems. His Surgery study incorporates themes from Odds ratio, Epidemiology, Combination therapy and Sulfasalazine.

His most cited work include:

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update (3425 citations)
  • The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection (1871 citations)
  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs (1282 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Internal medicine, Physical therapy, Rheumatoid arthritis, Ankylosing spondylitis and In patient. Robert Landewé has researched Internal medicine in several fields, including Gastroenterology, Placebo and Surgery. His research investigates the connection between Physical therapy and topics such as Clinical trial that intersect with issues in Observational study.

Robert Landewé has included themes like Methotrexate, Disease, Combination therapy and Arthritis in his Rheumatoid arthritis study. His Ankylosing spondylitis study integrates concerns from other disciplines, such as BASFI, BASDAI and Radiography. The Rheumatology study combines topics in areas such as Severity of illness and Etanercept.

He most often published in these fields:

  • Internal medicine (52.61%)
  • Physical therapy (31.07%)
  • Rheumatoid arthritis (29.25%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (52.61%)
  • Axial spondyloarthritis (17.01%)
  • In patient (22.34%)

In recent papers he was focusing on the following fields of study:

Robert Landewé focuses on Internal medicine, Axial spondyloarthritis, In patient, Ankylosing spondylitis and Cohort. His study ties his expertise on Placebo together with the subject of Internal medicine. Robert Landewé combines subjects such as Family medicine, Certolizumab pegol and Radiography with his study of Axial spondyloarthritis.

His work carried out in the field of Ankylosing spondylitis brings together such families of science as Randomized controlled trial, BASDAI, Severity of illness and Confounding. His Cohort research includes themes of Sacroiliitis, Disease, Generalized estimating equation, Back pain and Physical therapy. His Rheumatoid arthritis study combines topics in areas such as Clinical trial, Intensive care medicine and Arthritis.

Between 2017 and 2021, his most popular works were:

  • Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force (260 citations)
  • 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases (144 citations)
  • TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort (124 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Surgery

Robert Landewé spends much of his time researching Internal medicine, Ankylosing spondylitis, Axial spondyloarthritis, Rheumatoid arthritis and In patient. His Internal medicine research is multidisciplinary, incorporating elements of Placebo and Radiography. His study in Ankylosing spondylitis is interdisciplinary in nature, drawing from both Adalimumab, Severity of illness, Confounding and Clinical trial.

His Axial spondyloarthritis study combines topics from a wide range of disciplines, such as Latent transition analysis, Physical therapy, Magnetic resonance imaging and Class. His study focuses on the intersection of Physical therapy and fields such as Outcomes research with connections in the field of Absenteeism. He interconnects Disease activity, Methotrexate, Incidence and Arthritis in the investigation of issues within Rheumatoid arthritis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch.
Annals of the Rheumatic Diseases (2014)

3425 Citations

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

M Rudwaleit;D van der Heijde;R Landewé;J Listing.
Annals of the Rheumatic Diseases (2009)

3161 Citations

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

J. S. Smolen;R. Landewé;F. C. Breedveld;M. Dougados.
Revmatologiia (2011)

3007 Citations

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados.
Annals of the Rheumatic Diseases (2010)

2195 Citations

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang.
Arthritis & Rheumatism (2011)

1541 Citations

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

J. Sieper;M. Rudwaleit;X. Baraliakos;J. Brandt.
Annals of the Rheumatic Diseases (2009)

1494 Citations

Dickkopf-1 is a master regulator of joint remodeling

Danielle Diarra;Marina Stolina;Karin Polzer;Jochen Zwerina.
Nature Medicine (2007)

1397 Citations

The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general

M. Rudwaleit;D.M.F.M. van der Heijde;R.B.M. Landewé;N. Akkoc.
Annals of the Rheumatic Diseases (2011)

1336 Citations

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

Josef S Smolen;Ferdinand C Breedveld;Gerd R Burmester;Vivian Bykerk.
Annals of the Rheumatic Diseases (2016)

1121 Citations

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Bernard Combe;Robert Landewé;Cedric Lukas;Horatio D Bolosiu.
Annals of the Rheumatic Diseases (2006)

1097 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Robert Landewé

Paul Emery

Paul Emery

University of Leeds

Publications: 285

Désirée van der Heijde

Désirée van der Heijde

Leiden University Medical Center

Publications: 285

Maxime Dougados

Maxime Dougados

Hôpital Cochin

Publications: 240

Philip J. Mease

Philip J. Mease

University of Washington

Publications: 208

Josef S. Smolen

Josef S. Smolen

Medical University of Vienna

Publications: 203

Joachim Sieper

Joachim Sieper

Charité - University Medicine Berlin

Publications: 197

Laure Gossec

Laure Gossec

Sorbonne University

Publications: 197

Mikkel Østergaard

Mikkel Østergaard

University of Copenhagen

Publications: 193

Tore K. Kvien

Tore K. Kvien

University of Oslo

Publications: 186

Walter P. Maksymowych

Walter P. Maksymowych

University of Alberta

Publications: 161

Georg Schett

Georg Schett

University of Erlangen-Nuremberg

Publications: 155

Yoshiya Tanaka

Yoshiya Tanaka

University of Occupational and Environmental Health Japan

Publications: 150

Bruno Fautrel

Bruno Fautrel

Université Paris Cité

Publications: 146

Bernard Combe

Bernard Combe

University of Montpellier

Publications: 143

Daniel Aletaha

Daniel Aletaha

Medical University of Vienna

Publications: 134

Dafna D. Gladman

Dafna D. Gladman

Toronto Western Hospital

Publications: 134

Trending Scientists

Marek Chrobak

Marek Chrobak

University of California, Riverside

Jianzhuang Liu

Jianzhuang Liu

Huawei Technologies (China)

Leonard Meirovitch

Leonard Meirovitch

Virginia Tech

Daizhan Cheng

Daizhan Cheng

Chinese Academy of Sciences

Michael E. Casey

Michael E. Casey

Siemens (Germany)

Quanlin Liu

Quanlin Liu

University of Science and Technology Beijing

Min Yin

Min Yin

University of Science and Technology of China

Adam J. Birkenheuer

Adam J. Birkenheuer

North Carolina State University

Stanislav I. Tomarev

Stanislav I. Tomarev

National Institutes of Health

Matt Kaeberlein

Matt Kaeberlein

University of Washington

Peggy L. Olive

Peggy L. Olive

BC Cancer Research Centre

Andrea Truini

Andrea Truini

Sapienza University of Rome

Jonathan D. Wallis

Jonathan D. Wallis

University of California, Berkeley

Jorge Rakela

Jorge Rakela

Mayo Clinic

Lauren G. Block

Lauren G. Block

Baruch College

Thomas S. Robertson

Thomas S. Robertson

University of Pennsylvania

Something went wrong. Please try again later.